Naltrindole
Naltrindole is a highly potent, highly selective delta opioid receptor antagonist used in biomedical research.
Drug Design
Since peptide compounds are unable to cross the blood brain barrier, researchers developed naltrindole to be a non-peptide antagonist analog of the delta-preferring endogenous opiate enkephalin. Enkephalin contains an aromatic phenyl group on its Phe4 residue, which was hypothesized to be the “address” sequence responsible for the opiate’s delta opioid receptor affinity[1]. Thus, attachment of a phenyl-containing indole molecule to the C-ring of naltrexone‘s morphinan base successfully produced a drug with the high receptor affinity of naltrexone, but which binds almost exclusively to the delta opioid receptor[2].
References
- ↑ Lipkowski AW, Tam SW, Portoghese PS. “Peptides as receptor selectivity modulators of opiate pharmacophores.” Journal of Medicinal Chemistry. 1986 Jul;29(7):1222-5. PMID 2879914
- ↑ Portoghese PS, Sultana M, Takemori AE. “Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist.” European Journal of Pharmacology. 1988 Jan 27;146(1):185-6. PMID 2832195
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
